Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Albendazole 200mg/5ml oral suspension
0505030A0AAACAC
|
Albendazole | Albendazole | Infections | 1 |
|
Amoxicillin 1g powder for solution for injection vials
0501013C0AAAEAE
|
Amoxicillin sodium | Amoxicillin sodium | Infections | 1 |
|
Amoxil 125mg/1.25ml paediatric oral suspension
0501013B0BCAGAI
|
Amoxil (Systemic) | Amoxicillin | Infections | 1 |
|
Ampicillin 500mg powder for solution for injection vials
0501013E0AAADAD
|
Ampicillin | Ampicillin | Infections | 1 |
|
Augmentin Intravenous 1.2g inj vials
0501013K0BBAHAF
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 1 |
|
Augmentin Intravenous 600mg inj vials
0501013K0BBACAE
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 1 |
|
Avelox 400mg tablets
0501120Y0BBAAAA
|
Avelox | Moxifloxacin | Infections | 1 |
|
Biktarvy 30mg/120mg/15mg tablets
0503010AQBBABAB
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 1 |
|
Cefaclor 250mg capsules
0501021A0AAAAAA
|
Cefaclor | Cefaclor | Infections | 1 |
|
Ceftazidime 3g powder for solution for injection vials
0501021H0AAAHAH
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 1 |
|
Chloroquine phosphate 250mg tab and Proguanil 100mg tab
0504010Z0AAAAAA
|
Chloroquine phoshate/proguanil hydrochloride | Chloroquine phosphate with proguanil hydrochloride | Infections | 1 |
|
Ciproxin 750mg tablets
0501120L0BBADAJ
|
Ciproxin | Ciprofloxacin | Infections | 1 |
|
Clindamycin 300mg/2ml solution for injection ampoules
0501060E0AAAAAA
|
Clindamycin phosphate (Parenteral) | Clindamycin phosphate | Infections | 1 |
|
Clindamycin 75mg/5ml oral solution
0501060D0AAAEAE
|
Clindamycin hydrochloride (Systemic) | Clindamycin hydrochloride | Infections | 1 |
|
Cobicistat 150mg tablets
0503010AIAAAAAA
|
Cobicistat | Cobicistat | Infections | 1 |
|
Cycloserine 250mg capsules
0501090E0AAABAB
|
Cycloserine | Cycloserine | Infections | 1 |
|
Darunavir 400mg tablets
0503010ACAAABAB
|
Darunavir | Darunavir | Infections | 1 |
|
Descovy 200mg/10mg tablets
0503010AMBBAAAA
|
Descovy | Emtricitabine and tenofovir alafenamide | Infections | 1 |
|
Doxycycline 100mg/5ml oral suspension
0501030I0AAAKAK
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 1 |
|
Doxylar 100mg capsules
0501030I0BCAAAB
|
Doxylar | Doxycycline hyclate | Infections | 1 |
|
Ebilfumin 75mg capsules
0503040B0BCAAAA
|
Ebilfumin | Oseltamivir phosphate | Infections | 1 |
|
Efavirenz 600mg tablets
0503010D0AAADAD
|
Efavirenz | Efavirenz | Infections | 1 |
|
Erymax 250mg gastro-resistant capsules
0501050C0BCAAAK
|
Erymax | Erythromycin | Infections | 1 |
|
Ethambutol 300mg/5ml oral liquid
0501090H0AAAZAZ
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | 1 |
|
Floxapen 250mg/5ml syrup
0501012H0BBABAB
|
Floxapen (Liquid/Powder) | Flucloxacillin magnesium | Infections | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.